AbbVie Stock Forecast

Stock Price Forecast

According to 29 analysts polled by S&P Global, AbbVie stock has a consensus rating of "Buy" and an average price target of $310.65. The average 1-year stock price forecast is 6.17% higher than the current stock price, while the lowest is $237 (-19.00%) and the highest is $350 (+19.62%).

Price Target: $310.65 (+6.17%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$237	$310.65	$317	$350
Change	-19.00%	+6.17%	+8.34%	+19.62%

Analyst Ratings

The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	16	16	17	16	16	16
Buy	8	8	8	8	7	7
Hold	6	6	5	5	5	5
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	31	31	31	30	29	29

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ilya Zubkov Freedom Capital Markets	Freedom Capital Markets	Buy Maintains $285 → $315	Buy	Maintains	$285 → $315	+7.66%	Nov 4, 2026
Evan Seigerman BMO Capital	BMO Capital	Buy Maintains $340	Buy	Maintains	$340	+16.20%	Nov 3, 2026
David Risinger Leerink Partners	Leerink Partners	Buy Reiterates $279 → $325	Buy	Reiterates	$279 → $325	+11.07%	Nov 2, 2026
Carter Gould Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $290 → $325	Buy	Reiterates	$290 → $325	+11.07%	Nov 2, 2026
Vamil Divan Guggenheim	Guggenheim	Buy Reiterates $288 → $322	Buy	Reiterates	$288 → $322	+10.05%	Nov 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

67.80B

from 61.16B

10.86%

from 61.16B

Revenue Next Year

73.94B

from 67.80B

9.06%

from 67.80B

EPS This Year

13.98

from 10.00

39.83%

from 10.00

EPS Next Year

16.20

from 13.98

15.84%

from 13.98

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	56.20B	58.05B	54.32B	56.33B	61.16B	67.80B
Revenue Growth	22.69%	3.30%	-6.44%	3.71%	8.57%	10.86%
Operating Income	19.76B	20.23B	18.21B	17.42B	21.12B	31.67B
Net Income	11.54B	11.84B	4.86B	4.28B	4.23B	14.24B
EPS	-	-	-	-	10.00	13.98
EPS Growth	-	-	-	-	-1.19%	39.83%
Forward PE	10.04	12.72	13.96	14.81	16.57	20.93
Dividend / Share	5.31	5.71	5.99	6.29	6.65	6.90
Dividend Growth	9.71%	7.53%	4.90%	5.01%	5.72%	3.72%
Free Cash Flow	-	-	-	-	17.82B	20.25B
No. Analysts	-	-	-	-	-	24

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	68.0B
Avg	67.8B
Low	67.7B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	11.1%
Avg	10.9%
Low	10.7%

EPS Forecast

Chart

EPS	2026	2027	2028
High	14.13
Avg	13.98
Low	13.93

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	41.3%
Avg	39.8%
Low	39.3%